The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway

Andrea Casati, Guido Fanelli, Elisabetta Casaletti, Valeria Cedrati, Fabrizio Veglia, Giorgio Torri

Research output: Contribution to journalArticle

Abstract

To determine the target plasma concentration of propofol required to place either a laryngeal mask airway (LMA) or a cuffed oropharyngeal airway (COPA), we started a continuous target-controlled infusion of propofol in 60 ASA physical status I or II unpremedicated patients scheduled for minor orthopedic surgery with peripheral nerve block. The target plasma concentration of propofol was initially set at 2 μg/mL. When the effect- site calculated concentration of propofol was equal to the plasma concentration according to the computer simulation, the target plasma concentration was increased by 0.5-μg/mL steps until successful placement of either the LMA (n = 30) or the COPA (n = 30). The mean target plasma concentration of propofol required to place a LMA was 4.3 ± 0.8 μg/mL compared with 3.2 ± 0.6 μg/mL to place a COPA (P <0.001). To successfully place the airways in 95% of patients, the target plasma concentration of propofol had to be increased up to 4 μg/mL for the COPA and 6 μg/mL for the LMA. We conclude that placing a LMA in healthy, unpremedicated patients requires target plasma concentrations of propofol higher than those required for placing a COPA. Implications: We evaluated the use of target-controlled infusion of propofol to place extratracheal airways in this prospective, randomized study and demonstrated that the target plasma concentration of propofol required to successfully place a laryngeal mask in >95% of healthy, unpremedicated patients is 6 μg/mL, compared with 4 μg/mL to place a cuffed oropharyngeal airway.

Original languageEnglish
Pages (from-to)917-920
Number of pages4
JournalAnesthesia and Analgesia
Volume88
Issue number4
Publication statusPublished - Apr 1999

Fingerprint

Laryngeal Masks
Propofol
Minor Surgical Procedures
Nerve Block
Peripheral Nerves
Computer Simulation
Orthopedics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway. / Casati, Andrea; Fanelli, Guido; Casaletti, Elisabetta; Cedrati, Valeria; Veglia, Fabrizio; Torri, Giorgio.

In: Anesthesia and Analgesia, Vol. 88, No. 4, 04.1999, p. 917-920.

Research output: Contribution to journalArticle

Casati, A, Fanelli, G, Casaletti, E, Cedrati, V, Veglia, F & Torri, G 1999, 'The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway', Anesthesia and Analgesia, vol. 88, no. 4, pp. 917-920.
Casati, Andrea ; Fanelli, Guido ; Casaletti, Elisabetta ; Cedrati, Valeria ; Veglia, Fabrizio ; Torri, Giorgio. / The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway. In: Anesthesia and Analgesia. 1999 ; Vol. 88, No. 4. pp. 917-920.
@article{bad77ecf10bb48598b9f5e775d60aa7e,
title = "The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway",
abstract = "To determine the target plasma concentration of propofol required to place either a laryngeal mask airway (LMA) or a cuffed oropharyngeal airway (COPA), we started a continuous target-controlled infusion of propofol in 60 ASA physical status I or II unpremedicated patients scheduled for minor orthopedic surgery with peripheral nerve block. The target plasma concentration of propofol was initially set at 2 μg/mL. When the effect- site calculated concentration of propofol was equal to the plasma concentration according to the computer simulation, the target plasma concentration was increased by 0.5-μg/mL steps until successful placement of either the LMA (n = 30) or the COPA (n = 30). The mean target plasma concentration of propofol required to place a LMA was 4.3 ± 0.8 μg/mL compared with 3.2 ± 0.6 μg/mL to place a COPA (P <0.001). To successfully place the airways in 95{\%} of patients, the target plasma concentration of propofol had to be increased up to 4 μg/mL for the COPA and 6 μg/mL for the LMA. We conclude that placing a LMA in healthy, unpremedicated patients requires target plasma concentrations of propofol higher than those required for placing a COPA. Implications: We evaluated the use of target-controlled infusion of propofol to place extratracheal airways in this prospective, randomized study and demonstrated that the target plasma concentration of propofol required to successfully place a laryngeal mask in >95{\%} of healthy, unpremedicated patients is 6 μg/mL, compared with 4 μg/mL to place a cuffed oropharyngeal airway.",
author = "Andrea Casati and Guido Fanelli and Elisabetta Casaletti and Valeria Cedrati and Fabrizio Veglia and Giorgio Torri",
year = "1999",
month = "4",
language = "English",
volume = "88",
pages = "917--920",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway

AU - Casati, Andrea

AU - Fanelli, Guido

AU - Casaletti, Elisabetta

AU - Cedrati, Valeria

AU - Veglia, Fabrizio

AU - Torri, Giorgio

PY - 1999/4

Y1 - 1999/4

N2 - To determine the target plasma concentration of propofol required to place either a laryngeal mask airway (LMA) or a cuffed oropharyngeal airway (COPA), we started a continuous target-controlled infusion of propofol in 60 ASA physical status I or II unpremedicated patients scheduled for minor orthopedic surgery with peripheral nerve block. The target plasma concentration of propofol was initially set at 2 μg/mL. When the effect- site calculated concentration of propofol was equal to the plasma concentration according to the computer simulation, the target plasma concentration was increased by 0.5-μg/mL steps until successful placement of either the LMA (n = 30) or the COPA (n = 30). The mean target plasma concentration of propofol required to place a LMA was 4.3 ± 0.8 μg/mL compared with 3.2 ± 0.6 μg/mL to place a COPA (P <0.001). To successfully place the airways in 95% of patients, the target plasma concentration of propofol had to be increased up to 4 μg/mL for the COPA and 6 μg/mL for the LMA. We conclude that placing a LMA in healthy, unpremedicated patients requires target plasma concentrations of propofol higher than those required for placing a COPA. Implications: We evaluated the use of target-controlled infusion of propofol to place extratracheal airways in this prospective, randomized study and demonstrated that the target plasma concentration of propofol required to successfully place a laryngeal mask in >95% of healthy, unpremedicated patients is 6 μg/mL, compared with 4 μg/mL to place a cuffed oropharyngeal airway.

AB - To determine the target plasma concentration of propofol required to place either a laryngeal mask airway (LMA) or a cuffed oropharyngeal airway (COPA), we started a continuous target-controlled infusion of propofol in 60 ASA physical status I or II unpremedicated patients scheduled for minor orthopedic surgery with peripheral nerve block. The target plasma concentration of propofol was initially set at 2 μg/mL. When the effect- site calculated concentration of propofol was equal to the plasma concentration according to the computer simulation, the target plasma concentration was increased by 0.5-μg/mL steps until successful placement of either the LMA (n = 30) or the COPA (n = 30). The mean target plasma concentration of propofol required to place a LMA was 4.3 ± 0.8 μg/mL compared with 3.2 ± 0.6 μg/mL to place a COPA (P <0.001). To successfully place the airways in 95% of patients, the target plasma concentration of propofol had to be increased up to 4 μg/mL for the COPA and 6 μg/mL for the LMA. We conclude that placing a LMA in healthy, unpremedicated patients requires target plasma concentrations of propofol higher than those required for placing a COPA. Implications: We evaluated the use of target-controlled infusion of propofol to place extratracheal airways in this prospective, randomized study and demonstrated that the target plasma concentration of propofol required to successfully place a laryngeal mask in >95% of healthy, unpremedicated patients is 6 μg/mL, compared with 4 μg/mL to place a cuffed oropharyngeal airway.

UR - http://www.scopus.com/inward/record.url?scp=0032898113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032898113&partnerID=8YFLogxK

M3 - Article

C2 - 10195548

AN - SCOPUS:0032898113

VL - 88

SP - 917

EP - 920

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -